Global Oncology Immuno Drug Market Research Report 2026(Status and Outlook)
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body"s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Oncology Immuno Drug market size was estimated at USD 2541.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncology Immuno Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncology Immuno Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncology Immuno Drug market.
Global Oncology Immuno Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bristol-Myers Squibb
Merck & Co
Roche AG
AstraZeneca
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Market Segmentation (by Type)
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Other
Market Segmentation (by Application)
Hospitals
Drugstores
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncology Immuno Drug Market
Overview of the regional outlook of the Oncology Immuno Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Immuno Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Immuno Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oncology Immuno Drug market size was estimated at USD 2541.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncology Immuno Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncology Immuno Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncology Immuno Drug market.
Global Oncology Immuno Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bristol-Myers Squibb
Merck & Co
Roche AG
AstraZeneca
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Market Segmentation (by Type)
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Other
Market Segmentation (by Application)
Hospitals
Drugstores
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncology Immuno Drug Market
Overview of the regional outlook of the Oncology Immuno Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Immuno Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Immuno Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncology Immuno Drug
1.2 Key Market Segments
1.2.1 Oncology Immuno Drug Segment by Type
1.2.2 Oncology Immuno Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY IMMUNO DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Immuno Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncology Immuno Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY IMMUNO DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncology Immuno Drug Product Life Cycle
3.3 Global Oncology Immuno Drug Sales by Manufacturers (2020-2025)
3.4 Global Oncology Immuno Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncology Immuno Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncology Immuno Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncology Immuno Drug Market Competitive Situation and Trends
3.8.1 Oncology Immuno Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncology Immuno Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY IMMUNO DRUG INDUSTRY CHAIN ANALYSIS
4.1 Oncology Immuno Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY IMMUNO DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncology Immuno Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncology Immuno Drug Market
5.7 ESG Ratings of Leading Companies
6 ONCOLOGY IMMUNO DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Immuno Drug Sales Market Share by Type (2020-2025)
6.3 Global Oncology Immuno Drug Market Size by Type (2020-2025)
6.4 Global Oncology Immuno Drug Price by Type (2020-2025)
7 ONCOLOGY IMMUNO DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Immuno Drug Market Sales by Application (2020-2025)
7.3 Global Oncology Immuno Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Oncology Immuno Drug Sales Growth Rate by Application (2020-2025)
8 ONCOLOGY IMMUNO DRUG MARKET SALES BY REGION
8.1 Global Oncology Immuno Drug Sales by Region
8.1.1 Global Oncology Immuno Drug Sales by Region
8.1.2 Global Oncology Immuno Drug Sales Market Share by Region
8.2 Global Oncology Immuno Drug Market Size by Region
8.2.1 Global Oncology Immuno Drug Market Size by Region
8.2.2 Global Oncology Immuno Drug Market Size by Region
8.3 North America
8.3.1 North America Oncology Immuno Drug Sales by Country
8.3.2 North America Oncology Immuno Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncology Immuno Drug Sales by Country
8.4.2 Europe Oncology Immuno Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncology Immuno Drug Sales by Region
8.5.2 Asia Pacific Oncology Immuno Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncology Immuno Drug Sales by Country
8.6.2 South America Oncology Immuno Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncology Immuno Drug Sales by Region
8.7.2 Middle East and Africa Oncology Immuno Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLOGY IMMUNO DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Immuno Drug by Region(2020-2025)
9.2 Global Oncology Immuno Drug Revenue Market Share by Region (2020-2025)
9.3 Global Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncology Immuno Drug Production
9.4.1 North America Oncology Immuno Drug Production Growth Rate (2020-2025)
9.4.2 North America Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncology Immuno Drug Production
9.5.1 Europe Oncology Immuno Drug Production Growth Rate (2020-2025)
9.5.2 Europe Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncology Immuno Drug Production (2020-2025)
9.6.1 Japan Oncology Immuno Drug Production Growth Rate (2020-2025)
9.6.2 Japan Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncology Immuno Drug Production (2020-2025)
9.7.1 China Oncology Immuno Drug Production Growth Rate (2020-2025)
9.7.2 China Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Basic Information
10.1.2 Bristol-Myers Squibb Oncology Immuno Drug Product Overview
10.1.3 Bristol-Myers Squibb Oncology Immuno Drug Product Market Performance
10.1.4 Bristol-Myers Squibb Business Overview
10.1.5 Bristol-Myers Squibb SWOT Analysis
10.1.6 Bristol-Myers Squibb Recent Developments
10.2 Merck and Co
10.2.1 Merck and Co Basic Information
10.2.2 Merck and Co Oncology Immuno Drug Product Overview
10.2.3 Merck and Co Oncology Immuno Drug Product Market Performance
10.2.4 Merck and Co Business Overview
10.2.5 Merck and Co SWOT Analysis
10.2.6 Merck and Co Recent Developments
10.3 Roche AG
10.3.1 Roche AG Basic Information
10.3.2 Roche AG Oncology Immuno Drug Product Overview
10.3.3 Roche AG Oncology Immuno Drug Product Market Performance
10.3.4 Roche AG Business Overview
10.3.5 Roche AG SWOT Analysis
10.3.6 Roche AG Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Basic Information
10.4.2 AstraZeneca Oncology Immuno Drug Product Overview
10.4.3 AstraZeneca Oncology Immuno Drug Product Market Performance
10.4.4 AstraZeneca Business Overview
10.4.5 AstraZeneca Recent Developments
10.5 Sanofi S.A.
10.5.1 Sanofi S.A. Basic Information
10.5.2 Sanofi S.A. Oncology Immuno Drug Product Overview
10.5.3 Sanofi S.A. Oncology Immuno Drug Product Market Performance
10.5.4 Sanofi S.A. Business Overview
10.5.5 Sanofi S.A. Recent Developments
10.6 Dendreon Pharmaceuticals
10.6.1 Dendreon Pharmaceuticals Basic Information
10.6.2 Dendreon Pharmaceuticals Oncology Immuno Drug Product Overview
10.6.3 Dendreon Pharmaceuticals Oncology Immuno Drug Product Market Performance
10.6.4 Dendreon Pharmaceuticals Business Overview
10.6.5 Dendreon Pharmaceuticals Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Oncology Immuno Drug Product Overview
10.7.3 Novartis Oncology Immuno Drug Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 Gilead Sciences Inc.
10.8.1 Gilead Sciences Inc. Basic Information
10.8.2 Gilead Sciences Inc. Oncology Immuno Drug Product Overview
10.8.3 Gilead Sciences Inc. Oncology Immuno Drug Product Market Performance
10.8.4 Gilead Sciences Inc. Business Overview
10.8.5 Gilead Sciences Inc. Recent Developments
10.9 Merck KGaA
10.9.1 Merck KGaA Basic Information
10.9.2 Merck KGaA Oncology Immuno Drug Product Overview
10.9.3 Merck KGaA Oncology Immuno Drug Product Market Performance
10.9.4 Merck KGaA Business Overview
10.9.5 Merck KGaA Recent Developments
11 ONCOLOGY IMMUNO DRUG MARKET FORECAST BY REGION
11.1 Global Oncology Immuno Drug Market Size Forecast
11.2 Global Oncology Immuno Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Immuno Drug Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Immuno Drug Market Size Forecast by Region
11.2.4 South America Oncology Immuno Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncology Immuno Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncology Immuno Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncology Immuno Drug by Type (2026-2035)
12.1.2 Global Oncology Immuno Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncology Immuno Drug by Type (2026-2035)
12.2 Global Oncology Immuno Drug Market Forecast by Application (2026-2035)
12.2.1 Global Oncology Immuno Drug Sales (K MT) Forecast by Application
12.2.2 Global Oncology Immuno Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncology Immuno Drug
1.2 Key Market Segments
1.2.1 Oncology Immuno Drug Segment by Type
1.2.2 Oncology Immuno Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY IMMUNO DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Immuno Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncology Immuno Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY IMMUNO DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncology Immuno Drug Product Life Cycle
3.3 Global Oncology Immuno Drug Sales by Manufacturers (2020-2025)
3.4 Global Oncology Immuno Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncology Immuno Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncology Immuno Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncology Immuno Drug Market Competitive Situation and Trends
3.8.1 Oncology Immuno Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncology Immuno Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY IMMUNO DRUG INDUSTRY CHAIN ANALYSIS
4.1 Oncology Immuno Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY IMMUNO DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncology Immuno Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncology Immuno Drug Market
5.7 ESG Ratings of Leading Companies
6 ONCOLOGY IMMUNO DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Immuno Drug Sales Market Share by Type (2020-2025)
6.3 Global Oncology Immuno Drug Market Size by Type (2020-2025)
6.4 Global Oncology Immuno Drug Price by Type (2020-2025)
7 ONCOLOGY IMMUNO DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Immuno Drug Market Sales by Application (2020-2025)
7.3 Global Oncology Immuno Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Oncology Immuno Drug Sales Growth Rate by Application (2020-2025)
8 ONCOLOGY IMMUNO DRUG MARKET SALES BY REGION
8.1 Global Oncology Immuno Drug Sales by Region
8.1.1 Global Oncology Immuno Drug Sales by Region
8.1.2 Global Oncology Immuno Drug Sales Market Share by Region
8.2 Global Oncology Immuno Drug Market Size by Region
8.2.1 Global Oncology Immuno Drug Market Size by Region
8.2.2 Global Oncology Immuno Drug Market Size by Region
8.3 North America
8.3.1 North America Oncology Immuno Drug Sales by Country
8.3.2 North America Oncology Immuno Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncology Immuno Drug Sales by Country
8.4.2 Europe Oncology Immuno Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncology Immuno Drug Sales by Region
8.5.2 Asia Pacific Oncology Immuno Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncology Immuno Drug Sales by Country
8.6.2 South America Oncology Immuno Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncology Immuno Drug Sales by Region
8.7.2 Middle East and Africa Oncology Immuno Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLOGY IMMUNO DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Immuno Drug by Region(2020-2025)
9.2 Global Oncology Immuno Drug Revenue Market Share by Region (2020-2025)
9.3 Global Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncology Immuno Drug Production
9.4.1 North America Oncology Immuno Drug Production Growth Rate (2020-2025)
9.4.2 North America Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncology Immuno Drug Production
9.5.1 Europe Oncology Immuno Drug Production Growth Rate (2020-2025)
9.5.2 Europe Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncology Immuno Drug Production (2020-2025)
9.6.1 Japan Oncology Immuno Drug Production Growth Rate (2020-2025)
9.6.2 Japan Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncology Immuno Drug Production (2020-2025)
9.7.1 China Oncology Immuno Drug Production Growth Rate (2020-2025)
9.7.2 China Oncology Immuno Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Basic Information
10.1.2 Bristol-Myers Squibb Oncology Immuno Drug Product Overview
10.1.3 Bristol-Myers Squibb Oncology Immuno Drug Product Market Performance
10.1.4 Bristol-Myers Squibb Business Overview
10.1.5 Bristol-Myers Squibb SWOT Analysis
10.1.6 Bristol-Myers Squibb Recent Developments
10.2 Merck and Co
10.2.1 Merck and Co Basic Information
10.2.2 Merck and Co Oncology Immuno Drug Product Overview
10.2.3 Merck and Co Oncology Immuno Drug Product Market Performance
10.2.4 Merck and Co Business Overview
10.2.5 Merck and Co SWOT Analysis
10.2.6 Merck and Co Recent Developments
10.3 Roche AG
10.3.1 Roche AG Basic Information
10.3.2 Roche AG Oncology Immuno Drug Product Overview
10.3.3 Roche AG Oncology Immuno Drug Product Market Performance
10.3.4 Roche AG Business Overview
10.3.5 Roche AG SWOT Analysis
10.3.6 Roche AG Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Basic Information
10.4.2 AstraZeneca Oncology Immuno Drug Product Overview
10.4.3 AstraZeneca Oncology Immuno Drug Product Market Performance
10.4.4 AstraZeneca Business Overview
10.4.5 AstraZeneca Recent Developments
10.5 Sanofi S.A.
10.5.1 Sanofi S.A. Basic Information
10.5.2 Sanofi S.A. Oncology Immuno Drug Product Overview
10.5.3 Sanofi S.A. Oncology Immuno Drug Product Market Performance
10.5.4 Sanofi S.A. Business Overview
10.5.5 Sanofi S.A. Recent Developments
10.6 Dendreon Pharmaceuticals
10.6.1 Dendreon Pharmaceuticals Basic Information
10.6.2 Dendreon Pharmaceuticals Oncology Immuno Drug Product Overview
10.6.3 Dendreon Pharmaceuticals Oncology Immuno Drug Product Market Performance
10.6.4 Dendreon Pharmaceuticals Business Overview
10.6.5 Dendreon Pharmaceuticals Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Oncology Immuno Drug Product Overview
10.7.3 Novartis Oncology Immuno Drug Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 Gilead Sciences Inc.
10.8.1 Gilead Sciences Inc. Basic Information
10.8.2 Gilead Sciences Inc. Oncology Immuno Drug Product Overview
10.8.3 Gilead Sciences Inc. Oncology Immuno Drug Product Market Performance
10.8.4 Gilead Sciences Inc. Business Overview
10.8.5 Gilead Sciences Inc. Recent Developments
10.9 Merck KGaA
10.9.1 Merck KGaA Basic Information
10.9.2 Merck KGaA Oncology Immuno Drug Product Overview
10.9.3 Merck KGaA Oncology Immuno Drug Product Market Performance
10.9.4 Merck KGaA Business Overview
10.9.5 Merck KGaA Recent Developments
11 ONCOLOGY IMMUNO DRUG MARKET FORECAST BY REGION
11.1 Global Oncology Immuno Drug Market Size Forecast
11.2 Global Oncology Immuno Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Immuno Drug Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Immuno Drug Market Size Forecast by Region
11.2.4 South America Oncology Immuno Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncology Immuno Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncology Immuno Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncology Immuno Drug by Type (2026-2035)
12.1.2 Global Oncology Immuno Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncology Immuno Drug by Type (2026-2035)
12.2 Global Oncology Immuno Drug Market Forecast by Application (2026-2035)
12.2.1 Global Oncology Immuno Drug Sales (K MT) Forecast by Application
12.2.2 Global Oncology Immuno Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncology Immuno Drug Market Size by Type (M USD)
Table 4. Global Oncology Immuno Drug Market Size by Application
Table 5. Oncology Immuno Drug Market Size Comparison by Region (M USD)
Table 6. Global Oncology Immuno Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncology Immuno Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncology Immuno Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncology Immuno Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immuno Drug as of 2025)
Table 11. Global Market Oncology Immuno Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncology Immuno Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Immuno Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncology Immuno Drug Sales by Type (K MT)
Table 27. Global Oncology Immuno Drug Market Size by Type (M USD)
Table 28. Global Oncology Immuno Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Oncology Immuno Drug Sales Market Share by Type (2020-2025)
Table 30. Global Oncology Immuno Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncology Immuno Drug Market Share by Type (2020-2025)
Table 32. Global Oncology Immuno Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncology Immuno Drug Sales (K MT) by Application
Table 34. Global Oncology Immuno Drug Market Size by Application
Table 35. Global Oncology Immuno Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncology Immuno Drug Sales Market Share by Application (2020-2025)
Table 37. Global Oncology Immuno Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncology Immuno Drug Market Share by Application (2020-2025)
Table 39. Global Oncology Immuno Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncology Immuno Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncology Immuno Drug Sales Market Share by Region (2020-2025)
Table 42. Global Oncology Immuno Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncology Immuno Drug Market Size by Region (2020-2025)
Table 44. North America Oncology Immuno Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncology Immuno Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncology Immuno Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncology Immuno Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncology Immuno Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncology Immuno Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncology Immuno Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncology Immuno Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncology Immuno Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncology Immuno Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncology Immuno Drug Production (K MT) by Region(2020-2025)
Table 55. Global Oncology Immuno Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncology Immuno Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bristol-Myers Squibb Basic Information
Table 63. Bristol-Myers Squibb Oncology Immuno Drug Product Overview
Table 64. Bristol-Myers Squibb Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb SWOT Analysis
Table 67. Bristol-Myers Squibb Recent Developments
Table 68. Merck and Co Basic Information
Table 69. Merck and Co Oncology Immuno Drug Product Overview
Table 70. Merck and Co Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck and Co Business Overview
Table 72. Merck and Co SWOT Analysis
Table 73. Merck and Co Recent Developments
Table 74. Roche AG Basic Information
Table 75. Roche AG Oncology Immuno Drug Product Overview
Table 76. Roche AG Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Roche AG Business Overview
Table 78. Roche AG SWOT Analysis
Table 79. Roche AG Recent Developments
Table 80. AstraZeneca Basic Information
Table 81. AstraZeneca Oncology Immuno Drug Product Overview
Table 82. AstraZeneca Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Recent Developments
Table 85. Sanofi S.A. Basic Information
Table 86. Sanofi S.A. Oncology Immuno Drug Product Overview
Table 87. Sanofi S.A. Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sanofi S.A. Business Overview
Table 89. Sanofi S.A. Recent Developments
Table 90. Dendreon Pharmaceuticals Basic Information
Table 91. Dendreon Pharmaceuticals Oncology Immuno Drug Product Overview
Table 92. Dendreon Pharmaceuticals Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dendreon Pharmaceuticals Business Overview
Table 94. Dendreon Pharmaceuticals Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Oncology Immuno Drug Product Overview
Table 97. Novartis Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. Gilead Sciences Inc. Basic Information
Table 101. Gilead Sciences Inc. Oncology Immuno Drug Product Overview
Table 102. Gilead Sciences Inc. Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Inc. Business Overview
Table 104. Gilead Sciences Inc. Recent Developments
Table 105. Merck KGaA Basic Information
Table 106. Merck KGaA Oncology Immuno Drug Product Overview
Table 107. Merck KGaA Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Merck KGaA Business Overview
Table 109. Merck KGaA Recent Developments
Table 110. Global Oncology Immuno Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Oncology Immuno Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Oncology Immuno Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Oncology Immuno Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Oncology Immuno Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Oncology Immuno Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Oncology Immuno Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Oncology Immuno Drug Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Oncology Immuno Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncology Immuno Drug Market Size by Type (M USD)
Table 4. Global Oncology Immuno Drug Market Size by Application
Table 5. Oncology Immuno Drug Market Size Comparison by Region (M USD)
Table 6. Global Oncology Immuno Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncology Immuno Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncology Immuno Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncology Immuno Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immuno Drug as of 2025)
Table 11. Global Market Oncology Immuno Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncology Immuno Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Immuno Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncology Immuno Drug Sales by Type (K MT)
Table 27. Global Oncology Immuno Drug Market Size by Type (M USD)
Table 28. Global Oncology Immuno Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Oncology Immuno Drug Sales Market Share by Type (2020-2025)
Table 30. Global Oncology Immuno Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncology Immuno Drug Market Share by Type (2020-2025)
Table 32. Global Oncology Immuno Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncology Immuno Drug Sales (K MT) by Application
Table 34. Global Oncology Immuno Drug Market Size by Application
Table 35. Global Oncology Immuno Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncology Immuno Drug Sales Market Share by Application (2020-2025)
Table 37. Global Oncology Immuno Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncology Immuno Drug Market Share by Application (2020-2025)
Table 39. Global Oncology Immuno Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncology Immuno Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncology Immuno Drug Sales Market Share by Region (2020-2025)
Table 42. Global Oncology Immuno Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncology Immuno Drug Market Size by Region (2020-2025)
Table 44. North America Oncology Immuno Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncology Immuno Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncology Immuno Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncology Immuno Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncology Immuno Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncology Immuno Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncology Immuno Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncology Immuno Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncology Immuno Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncology Immuno Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncology Immuno Drug Production (K MT) by Region(2020-2025)
Table 55. Global Oncology Immuno Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncology Immuno Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncology Immuno Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bristol-Myers Squibb Basic Information
Table 63. Bristol-Myers Squibb Oncology Immuno Drug Product Overview
Table 64. Bristol-Myers Squibb Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb SWOT Analysis
Table 67. Bristol-Myers Squibb Recent Developments
Table 68. Merck and Co Basic Information
Table 69. Merck and Co Oncology Immuno Drug Product Overview
Table 70. Merck and Co Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck and Co Business Overview
Table 72. Merck and Co SWOT Analysis
Table 73. Merck and Co Recent Developments
Table 74. Roche AG Basic Information
Table 75. Roche AG Oncology Immuno Drug Product Overview
Table 76. Roche AG Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Roche AG Business Overview
Table 78. Roche AG SWOT Analysis
Table 79. Roche AG Recent Developments
Table 80. AstraZeneca Basic Information
Table 81. AstraZeneca Oncology Immuno Drug Product Overview
Table 82. AstraZeneca Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Recent Developments
Table 85. Sanofi S.A. Basic Information
Table 86. Sanofi S.A. Oncology Immuno Drug Product Overview
Table 87. Sanofi S.A. Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sanofi S.A. Business Overview
Table 89. Sanofi S.A. Recent Developments
Table 90. Dendreon Pharmaceuticals Basic Information
Table 91. Dendreon Pharmaceuticals Oncology Immuno Drug Product Overview
Table 92. Dendreon Pharmaceuticals Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Dendreon Pharmaceuticals Business Overview
Table 94. Dendreon Pharmaceuticals Recent Developments
Table 95. Novartis Basic Information
Table 96. Novartis Oncology Immuno Drug Product Overview
Table 97. Novartis Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Novartis Business Overview
Table 99. Novartis Recent Developments
Table 100. Gilead Sciences Inc. Basic Information
Table 101. Gilead Sciences Inc. Oncology Immuno Drug Product Overview
Table 102. Gilead Sciences Inc. Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Inc. Business Overview
Table 104. Gilead Sciences Inc. Recent Developments
Table 105. Merck KGaA Basic Information
Table 106. Merck KGaA Oncology Immuno Drug Product Overview
Table 107. Merck KGaA Oncology Immuno Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Merck KGaA Business Overview
Table 109. Merck KGaA Recent Developments
Table 110. Global Oncology Immuno Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Oncology Immuno Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Oncology Immuno Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Oncology Immuno Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Oncology Immuno Drug Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Oncology Immuno Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Oncology Immuno Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Oncology Immuno Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Oncology Immuno Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Oncology Immuno Drug Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Oncology Immuno Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncology Immuno Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Immuno Drug Market Size (M USD), 2025-2035
Figure 5. Global Oncology Immuno Drug Market Size (M USD) (2020-2035)
Figure 6. Global Oncology Immuno Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Immuno Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncology Immuno Drug Product Life Cycle
Figure 13. Oncology Immuno Drug Sales Share by Manufacturers in 2025
Figure 14. Global Oncology Immuno Drug Revenue Share by Manufacturers in 2025
Figure 15. Oncology Immuno Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncology Immuno Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncology Immuno Drug Revenue in 2025
Figure 18. Industry Chain Map of Oncology Immuno Drug
Figure 19. Global Oncology Immuno Drug Market PEST Analysis
Figure 20. Global Oncology Immuno Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncology Immuno Drug Market Share by Type
Figure 27. Sales Market Share of Oncology Immuno Drug by Type (2020-2025)
Figure 28. Sales Market Share of Oncology Immuno Drug by Type in 2025
Figure 29. Market Share of Oncology Immuno Drug by Type (2020-2025)
Figure 30. Market Share of Oncology Immuno Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncology Immuno Drug Market Share by Application
Figure 33. Global Oncology Immuno Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Oncology Immuno Drug Sales Market Share by Application in 2025
Figure 35. Global Oncology Immuno Drug Market Share by Application (2020-2025)
Figure 36. Global Oncology Immuno Drug Market Share by Application in 2025
Figure 37. Global Oncology Immuno Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncology Immuno Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Oncology Immuno Drug Market Size by Region (2020-2025)
Figure 40. North America Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncology Immuno Drug Sales Market Share by Country in 2024
Figure 43. North America Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncology Immuno Drug Market Size by Country in 2024
Figure 45. U.S. Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncology Immuno Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncology Immuno Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncology Immuno Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncology Immuno Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncology Immuno Drug Sales Market Share by Country in 2024
Figure 53. Europe Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncology Immuno Drug Market Size by Country in 2024
Figure 55. Germany Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncology Immuno Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncology Immuno Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncology Immuno Drug Market Size by Region in 2024
Figure 68. China Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncology Immuno Drug Sales and Growth Rate (K MT)
Figure 79. South America Oncology Immuno Drug Sales Market Share by Country in 2024
Figure 80. South America Oncology Immuno Drug Market Size and Growth Rate (M USD)
Figure 81. South America Oncology Immuno Drug Market Size by Country in 2024
Figure 82. Brazil Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncology Immuno Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncology Immuno Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncology Immuno Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncology Immuno Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncology Immuno Drug Production Market Share by Region (2020-2025)
Figure 103. North America Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncology Immuno Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncology Immuno Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncology Immuno Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncology Immuno Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncology Immuno Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Oncology Immuno Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Oncology Immuno Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Immuno Drug Market Size (M USD), 2025-2035
Figure 5. Global Oncology Immuno Drug Market Size (M USD) (2020-2035)
Figure 6. Global Oncology Immuno Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Immuno Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncology Immuno Drug Product Life Cycle
Figure 13. Oncology Immuno Drug Sales Share by Manufacturers in 2025
Figure 14. Global Oncology Immuno Drug Revenue Share by Manufacturers in 2025
Figure 15. Oncology Immuno Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncology Immuno Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncology Immuno Drug Revenue in 2025
Figure 18. Industry Chain Map of Oncology Immuno Drug
Figure 19. Global Oncology Immuno Drug Market PEST Analysis
Figure 20. Global Oncology Immuno Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncology Immuno Drug Market Share by Type
Figure 27. Sales Market Share of Oncology Immuno Drug by Type (2020-2025)
Figure 28. Sales Market Share of Oncology Immuno Drug by Type in 2025
Figure 29. Market Share of Oncology Immuno Drug by Type (2020-2025)
Figure 30. Market Share of Oncology Immuno Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncology Immuno Drug Market Share by Application
Figure 33. Global Oncology Immuno Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Oncology Immuno Drug Sales Market Share by Application in 2025
Figure 35. Global Oncology Immuno Drug Market Share by Application (2020-2025)
Figure 36. Global Oncology Immuno Drug Market Share by Application in 2025
Figure 37. Global Oncology Immuno Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncology Immuno Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Oncology Immuno Drug Market Size by Region (2020-2025)
Figure 40. North America Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncology Immuno Drug Sales Market Share by Country in 2024
Figure 43. North America Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncology Immuno Drug Market Size by Country in 2024
Figure 45. U.S. Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncology Immuno Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncology Immuno Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncology Immuno Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncology Immuno Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncology Immuno Drug Sales Market Share by Country in 2024
Figure 53. Europe Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncology Immuno Drug Market Size by Country in 2024
Figure 55. Germany Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncology Immuno Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncology Immuno Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncology Immuno Drug Market Size by Region in 2024
Figure 68. China Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncology Immuno Drug Sales and Growth Rate (K MT)
Figure 79. South America Oncology Immuno Drug Sales Market Share by Country in 2024
Figure 80. South America Oncology Immuno Drug Market Size and Growth Rate (M USD)
Figure 81. South America Oncology Immuno Drug Market Size by Country in 2024
Figure 82. Brazil Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncology Immuno Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncology Immuno Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncology Immuno Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncology Immuno Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncology Immuno Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncology Immuno Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncology Immuno Drug Production Market Share by Region (2020-2025)
Figure 103. North America Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncology Immuno Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncology Immuno Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncology Immuno Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncology Immuno Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncology Immuno Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncology Immuno Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Oncology Immuno Drug Market Share Forecast by Application (2026-2035)
